Cipla Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CIPLA LTD, and what generic and branded alternatives to CIPLA LTD drugs are available?
CIPLA LTD has ten approved drugs.
There are eight tentative approvals on CIPLA LTD drugs.
Summary for Cipla Ltd
US Patents: | 0 |
Tradenames: | 9 |
Ingredients: | 9 |
NDAs: | 10 |
Drug Master File Entries: | 217 |
Patent Litigation for Cipla Ltd: | See patent lawsuits for Cipla Ltd |
PTAB Cases with Cipla Ltd as petitioner: | See PTAB cases with Cipla Ltd as petitioner |
Drugs and US Patents for Cipla Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cipla Ltd | ZIDOVUDINE | zidovudine | SOLUTION;ORAL | 077981-001 | Jun 26, 2008 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cipla Ltd | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 077219-002 | Feb 20, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Cipla Ltd | EPIRUBICIN HYDROCHLORIDE | epirubicin hydrochloride | INJECTABLE;INJECTION | 065361-001 | Oct 22, 2007 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cipla Ltd | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 077219-001 | Feb 20, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Cipla Ltd | STAVUDINE | stavudine | FOR SOLUTION;ORAL | 078030-001 | Mar 20, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Cipla Ltd | TOPIRAMATE | topiramate | TABLET;ORAL | 076343-004 | Mar 27, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |